Company News

The Lancet Neurology publishes the first-ever randomised controlled trial to investigate the efficacy of the ketogenic therapy. This is the strongest demonstration yet that ketogenic therapy provides a proven alternative in an area of medicine where drugs have had limited success. Rob Crim, Managing Director of SHS, congratulates Dr Neal, Professor Cross and their colleagues on their success in leading this work at Great Ormond Street Hospital. To find out more click here.